A little bit for everyone
Full story can be found at
http://money.aol.com/news/articles?id=n20060407145809990001
it's clear that big U.S. stocks face much more competition for investor dollars than ever before. With nearly everything else working, why should investors bother with blue chips?
Strategists citing the cyclical argument have been predicting a blue chip comeback for 18 months. It hasn't happened yet.
"The time to make money," said Lord Rothschild, "is when there is blood on the streets." Big stocks are clearly wounded. "It actually hurts to say this again," wrote ISI's Trennert in a Feb. 27 research note to clients, "but we believe large caps are due."
Meanwhile, another Fidelity fund, $50 billion Magellan, recently dumped blue chips Pfizer, Intel, and Procter & Gamble and boosted its foreign holdings to 25%, up from 4% just a few months ago.
Bank on this: The blue chips will see another bull market, and perhaps soon. But with so many choices at investors' fingertips, the easy money may have already been made. Diversification is back. And that's not a bad thing.
Since 2003, net flows to international-stock mutual funds have more than tripled, to $150 billion, while flows into U.S. funds have plunged from $154 billion to $64 billion. In January, foreign equity funds' inflows almost doubled those of December.